Vaccine Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The vaccine delivery devices market is segmented by Product Type (Syringes, Jet Injectors, Other Product Types), End Users (Hospitals, Clinics & Other End Users), Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The report offers the value (in USD million) for the above segments.

Market Snapshot

Vaccine Delivery Devices Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The vaccine delivery devices market is expected to register a CAGR of 6.7% over the forecast period 2022-2027.

At first, the COVID-19 pandemic had a substantial impact on the vaccine delivery device market due to the unexpected spread. The article "Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky, published in May 2022 by Harm Reduction Journal, points out how the pandemic reduced and affected the syringe services programs and vaccinations regionally and globally.

Further, the increasing rate of different pandemics, which leads to other comorbidities, is a major factor driving the demand for vaccine delivery devices, thereby contributing to market growth. The article "Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing," published in the MDPI journal in 2021, reveals the increased demand for vaccination which leads to the point of high supply of vaccines. This highlights the need for vaccination, leading to the demand for the vaccine delivery device market.

Furthermore, market players are engaged in marketing tactics such as mergers and acquisitions and product launches. For instance, in May 2022, Becton, Dickinson and Company, and Mitsubishi Gas Chemical signed a letter of intent (LOI) to discuss establishing a partnership to develop innovative biological drug delivery methods OXYCAPTTM, that combines the best of plastic and glass for plastic syringes. Several pharmacological substances based on technologies such as mRNA, viral vectors, or novel antibodies may confront special stability or device integration problems when packaged and administered in glass prefilled syringes. Becton, Dickinson and Company, and Mitsubishi Gas Chemical will collaborate to find practical alternatives for delivering newer biological substances. Both companies are dedicated to improving sustainability and lowering their carbon footprint.

Growing immunization programs, investment in vaccine research, and developing novel drug delivery technologies fuel the market for vaccine delivery devices. Furthermore, the industry's growth is aided by new product launches and strategic efforts by significant market competitors. For example, in May 2022, Gerresheimer and Portal partnered to treat chronically ill patients using a needle-free medicine delivery system. Gerresheimar has invested in Portal Instruments, a developer of next-generation needle-free medicine delivery technology based in the United States. The partners hope to improve the patient experience by altering the administration of injectable drugs. Portal creates technology that enables needle-free, high-speed subcutaneous injection of medicine and, via connectivity, patient and medical care provider adherence monitoring throughout the treatment path.

As a result of the reasons outlined, the explored market is anticipated to grow throughout the analysis period. However, the costs of microneedles restrain the vaccine delivery devices' market growth.

Scope of the Report

As per the scope of the report, vaccine delivery devices are devices intended to deliver the vaccine, a biological preparation that improves immunity to a particular disease. The vaccine delivery devices market is segmented by Product Type (Syringes, Jet Injectors, Other Product Types), End Users (Hospitals, Clinics & Other End Users), Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type
Jet Injectors
Other Product Types
By End-User
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Syringes are Expected to Witness a Positive Growth Over the Forecast Period

Syringes are devices used to inject medication into or withdraw fluid from the body. It's most widely used to inject vaccines into the human body. There are different syringe measures according to the intravenous, intramuscular, and intradermal requirements. Being used widely in hospitals and clinics, syringes serve a huge part in the vaccine delivery devices market.

The study published in PubMed in 2022, "The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study," explains that temporary interruption and permanent closure of existing syringe services programs operating in the rural United States may lead to a 'rebound' HIV outbreaks. This depicts the need for syringes in a current and future scenario. There is no other quick alternative to syringes in such conditions.

The news bulletin published in November 2021 in United Nations News under the title "COVID-19 pandemic brings global syringe shortage into sharp focus" strongly spells out the fact that along with the global vaccination, there can be a scarcity in syringes as the number of vaccinations are scaling up. The World health organization mentioned that efforts to increase COVID-19 vaccine manufacturing should be matched by access to the syringes required to inject the vaccine - and there may even be a global scarcity of needles for normal immunization programs next year.

Hence, owing to the above-mentioned scenarios, there will be a definite amount of demand for the syringes in the upcoming years.

Furthermore, in 2022, in the Human Vaccines & Immunotherapeutics journal, the article "Syringes must be prioritized globally to ensure equitable access to COVID-19 and other essential vaccines and to sustain safe injection practices "substantiate that the Auto disabled (AD) syringes have been a major component of global COVID-19 vaccination programs, and they are essential for sustaining safe injection practices for routine immunization and pandemic response.

The article published in 2022 in the International Journal of Natural Sciences, "An Investigational Study on Prefilled Syringe Formulation Registration in the US and EU," elucidates several important facts, including the following: versatility, availability, accuracy, sterility, protection, marketing, production, and marketing are all advantages of prefilled syringes. Because of the advantages it offers over traditional pharmaceutical containers like vials and ampoules, the prefilled syringe is gaining widespread usage in the pharmaceutical industry.

As a result of the aforementioned factors, the syringe segment is predicted to develop significantly throughout the forecast period.

Vaccine Delivery Devices Market Trends

North America is Expected to Lead the Vaccine Delivery Devices Market

In 2021, North America held most of the market share for vaccine delivery devices. The emergence of this region can be attributed to an increase in pandemics in the United States and the rest of North America, as well as enhanced trials and studies for vaccine development. Increased investment in research and development to bring new vaccination technologies to market is also expected to boost the region's market. According to a report published by European Commission in June 2021, the United States holds most of the shares in the research and development of vaccines. As per the news releases on May 2022 in the National Institute of Allergy and Infectious Disease, the development of clinical trials shows promising results for a vaccine for Rare but deadly mosquito-borne viruses. The vaccine is developed by the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health. National Institute of Allergy and Infectious Diseases sponsored and funded this clinical trial.

Key product releases, the quick spread of pandemics, increased vaccination awareness, and the presence of manufacturers in the country are all factors that have contributed to the growth of the vaccine delivery devices market. According to the press release on December 2020, New Jersey-based Becton, Dickinson, and Company, in support of global COVID-19 Vaccination Efforts, reached a 2 billion Injection Device Milestone. In addition to assisting with initial COVID-19 vaccine preparations, they are investing USD 1.2 billion over four years to expand and upgrade manufacturing capacity and technology for pre-fillable syringes and advanced drug delivery systems, allowing for the continued development of new injectable drugs and vaccines while also providing surge capacity for increased pre-fillable syringe demand during pandemic response.

The analyzed market is predicted to grow in the North American region due to the preceding factors.

Vaccine Delivery Devices Market Analysis

Competitive Landscape

The vaccine delivery devices market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold the market shares and are well known. Include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo, Gerresheimer AG, and PharmaJet Inc., among others.

Recent Developments

In August 2021, SCHOTT and the Serum Institute of India formed a pharmaceutical packaging joint venture. Serum Institute of India, the world's largest vaccine producer and manufacturer of highly effective biologics, has purchased a 50% stake in SCHOTT, a German specialty glass company. The Serum is guaranteeing its supply of high-quality pharma packaging with this acquisition in the face of escalating worldwide demand.

In November 2021, Midas Pharma and Gerresheimer announced a strategic alliance. Their joint project comprises the development and marketing of the new generation autoinjector. The go-to-market approach for the autoinjector combines the complementary strengths of both companies - Gerresheimer as a solution provider for medical devices and primary packaging solutions and Midas Pharma as an experienced facilitator for global pharma projects and provider of products and services along the pharmaceutical value chain.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Immunization Program and Investment for Vaccine Research

      2. 4.2.2 Development in Novel Drug Delivery Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 High cost for micro needles

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Syringes

      2. 5.1.2 Jet Injectors

      3. 5.1.3 Other Product Types

    2. 5.2 By End-User

      1. 5.2.1 Hospitals

      2. 5.2.2 Clinics

      3. 5.2.3 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Becton, Dickinson and Company

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Terumo

      4. 6.1.4 Zhejiang Longde Pharmaceutical Co., Ltd

      5. 6.1.5 Hutem

      6. 6.1.6 Hindustan Syringes & Medical Devices Ltd

      7. 6.1.7 Gerresheimer AG

      8. 6.1.8 SCHOTT AG

      9. 6.1.9 Enesi Pharma

      10. 6.1.10 PharmaJet Inc.

      11. 6.1.11 Mystic Pharmaceuticals Inc

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Vaccine Delivery Devices Market market is studied from 2019 - 2027.

The Global Vaccine Delivery Devices Market is growing at a CAGR of 6.7% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Terumo, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, PharmaJet Inc. are the major companies operating in Global Vaccine Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!